Skip to search formSkip to main contentSkip to account menu

ADAM17 gene

Known as: A DISINTEGRIN AND METALLOPROTEINASE DOMAIN 17, ADAM metallopeptidase domain 17, TUMOR NECROSIS FACTOR-ALPHA CONVERTING ENZYME 
This gene plays a role in the cleavage of membrane proteins, resulting in the release of their extracellular domains from cells.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Metastasis is the major cause of death in cancer patients. Especially, patients undergoing primary tumor resection are at a high… 
Review
2018
Review
2018
// XuFeng Peng 1, * , Bo Hao 3, * , Nailong Cao 1 , Jihong Wang 1 , Xiangguo Lv 2 and XinRu Zhang 1 1 Department of Urology… 
2017
2017
Platelets are the sole source of EGF in the circulation, yet how EGF is stored or released from stimulated cells are undefined… 
2017
2017
  • 2017
  • Corpus ID: 171084614
The anti-TACE antibody comes with an extensive package of data demonstrating high affinity binding, potent inhibitory action… 
2014
2014
A disintegrin and metalloprotease (ADAM) 17 has been implicated in the tumor progression of various types of solid tumor; however… 
2013
2013
A quantitative structure-activity relationship (QSAR) study has been carried out on a new series of tartrate-based compounds to… 
2011
2011
Oncogenic mutations in Kras occur in 40% to 45% of patients with advanced colorectal cancer (CRC). We have previously shown that… 
2010
2008
2008
SummaryIn order to investigate the effects of LPS on the TACE gene transcription and expression and its regulating effect on the… 
2006
2006
Background—Angiotensin II (Ang II) promotes growth of vascular smooth muscle cells (VSMCs) via epidermal growth factor (EGF…